World News | Agence France-Presse | Wednesday March 23, 2022
US biotech firm Moderna on Wednesday said it was pursuing regulatory approval for its Covid vaccine in children aged six months to six years after the two-shot regimen was found to be safe and produced a strong immune response.
www.ndtv.com